V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215178 | 20130272 | 1.69 | 50.4 | null | 2019-07-07 | 2019-07-19 | Sorafenib | 02 | null | SORAFENIB | 101198769 |
| 20215179 | 20130273 | 1.83 | 65.4 | Adjuvant (A) | 2017-07-09 | 2017-07-09 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101663089 |
| 20215181 | 20130274 | 1.7 | 70.6 | Palliative (P) | 2018-09-02 | 2018-10-16 | Trial Unspecified | N | N | TRIAL | 101462301 |
| 20215182 | 20130275 | null | 69.6 | Palliative (P) | 2019-05-25 | 2019-06-01 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101244595 |
| 20215185 | 20130276 | 1.56 | 87 | Palliative (P) | 2015-07-04 | 2015-07-16 | Trial Unspecified | Y | N | TRIAL | 101370725 |
| 20215186 | 20130277 | 1.73 | 76.5 | Curative (C) | 2018-09-29 | 2018-10-03 | Oxaliplatin + Raltitrexed | N | N | OXALIPLATIN + RALTITREXED | 100741075 |
| 20215189 | 20130278 | 1.64 | 84 | null | 2019-07-01 | 2019-07-15 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101558632 |
| 20215191 | 20130279 | 1.83 | 80.4 | Palliative (P) | 2017-01-04 | 2017-01-29 | Oxaliplatin + Raltitrexed | N | N | CETUXIMAB + IRINOTECAN + MDG | 100148502 |
| 20215192 | 20130280 | 1.6 | 97.3 | Palliative (P) | 2019-10-06 | 2019-10-29 | EOX | 99 | null | CETUXIMAB + IRINOTECAN + MDG | 101661841 |
| 20215194 | 20130281 | null | 73.4 | Palliative (P) | 2019-11-28 | 2019-12-06 | EOX | N | N | EOX | 101774733 |
| 20215200 | 20130282 | 1.8 | 73.6 | Disease modification (D) | 2017-06-02 | 2017-06-02 | EOX | N | Y | EOX | 101722575 |
| 20215202 | 20130283 | 1.45 | 61.2 | Palliative (P) | 2018-07-28 | 2018-08-11 | Trial Unspecified | 02 | N | TRIAL | 100829309 |
| 20215203 | 20130284 | 1.86 | 70.95 | null | null | 2020-05-07 | Sorafenib | 02 | null | SORAFENIB | 101820639 |
| 20215204 | 20130285 | 1.79 | 74.5 | Curative (C) | 2019-10-30 | 2019-10-31 | Oxaliplatin + Raltitrexed | 01 | Y | OXALIPLATIN + RALTITREXED | 101359174 |
| 20215205 | 20130286 | 1.69 | 100.5 | Adjuvant (A) | 2015-11-21 | 2016-02-27 | EOX | N | null | TRIAL | 101605789 |
| 20215206 | 20130287 | 1.59 | 89.3 | null | 2020-06-26 | 2020-11-06 | EOX | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100066797 |
| 20215208 | 20130288 | 1.75 | 52.9 | Palliative (P) | 2017-04-18 | 2017-04-20 | Sorafenib | 02 | N | SORAFENIB | 100866945 |
| 20215209 | 20130289 | 1.74 | 72 | null | 2019-03-23 | 2019-04-17 | Trial Unspecified | null | Y | TRIAL | 100151323 |
| 20215210 | 20130290 | 1.76 | 69.5 | Palliative (P) | 2018-12-02 | 2019-03-29 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101350211 |
| 20215211 | 20130291 | 1.83 | 52 | Palliative (P) | 2020-03-13 | 2020-03-21 | EOX | 2 | N | SORAFENIB | 100797482 |
| 20215214 | 20130292 | 1.6 | 68.3 | Palliative (P) | 2020-05-07 | 2020-05-17 | EOX | N | Y | CETUXIMAB + IRINOTECAN + MDG | 100926598 |
| 20215216 | 20130293 | 1.62 | 100.8 | Palliative (P) | 2017-06-02 | 2017-10-27 | EOX | Y | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100665266 |
| 20215217 | 20130294 | 1.62 | 71.6 | Palliative (P) | 2018-07-27 | 2018-08-03 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101077415 |
| 20215219 | 20130295 | 1.67 | 61 | Curative (C) | 2019-02-08 | 2019-05-23 | EOX | 02 | null | TRIAL | 101426116 |
| 20215221 | 20130296 | 1.76 | 56.6 | Palliative (P) | 2016-03-28 | 2016-04-18 | IRINOTECAN + MDG + PANITUMUMAB | 01 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101153027 |
| 20215222 | 20130297 | 1.72 | 59 | Palliative (P) | 2018-04-14 | 2018-04-22 | Trial Unspecified | N | N | TRIAL | 101064900 |
| 20215223 | 20130298 | 1.81 | 95.2 | Curative (C) | 2018-08-16 | 2018-08-17 | Sorafenib | N | N | SORAFENIB | 100153549 |
| 20215224 | 20130299 | 1.75 | 54.6 | Palliative (P) | 2017-12-27 | 2018-01-03 | EOX | N | N | OXALIPLATIN + RALTITREXED | 100969979 |
| 20215225 | 20130300 | 1.57 | 78.5 | Palliative (P) | null | 2019-04-08 | Trial Unspecified | N | N | TRIAL | 101251188 |
| 20215229 | 20130301 | 1.72 | 70.4 | null | 2021-01-15 | 2021-01-21 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 100418435 |
| 20215231 | 20130302 | 0 | 80.4 | Palliative (P) | 2018-10-05 | 2018-10-24 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 2 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101591861 |
| 20215232 | 20130303 | null | 114.2 | null | 2017-06-28 | 2017-07-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 101160496 |
| 20215235 | 20130304 | 1.76 | 47.3 | null | 2019-08-08 | 2019-09-22 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100631339 |
| 20215236 | 20130305 | 1.79 | 64 | null | 2016-12-18 | 2017-08-14 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 100010670 |
| 20215238 | 20130306 | 1.66 | 61.6 | Palliative (P) | 2019-09-25 | 2019-09-26 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101305267 |
| 20215239 | 20130307 | 1.54 | 76 | Palliative (P) | 2019-02-26 | 2019-02-26 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100518325 |
| 20215244 | 20130308 | 1.74 | 54.7 | Adjuvant (A) | 2017-09-25 | 2017-10-16 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 01 | Y | CETUXIMAB + IRINOTECAN + MDG | 101767037 |
| 20215245 | 20130309 | 1.92 | 44 | Curative (C) | 2019-02-15 | 2019-08-10 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100354314 |
| 20215252 | 20130310 | 1.57 | 78.5 | Palliative (P) | 2019-08-22 | 2019-08-22 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100518125 |
| 20215254 | 20130311 | 1.6 | 93.3 | Palliative (P) | 2018-07-11 | 2018-07-13 | Trial Unspecified | 02 | N | TRIAL | 101474901 |
| 20215255 | 20130312 | 1.85 | 85 | Neo-adjuvant (N) | 2019-04-16 | 2020-03-03 | Oxaliplatin + Raltitrexed | 02 | Y | OXALIPLATIN + RALTITREXED | 100665167 |
| 20215257 | 20130313 | 1.75 | 78.2 | Palliative (P) | 2017-06-06 | 2017-06-07 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101140880 |
| 20215260 | 20130314 | 1.6 | 70.6 | null | null | 2017-07-09 | Cetuximab + FOLFIRI cycle 2 onwards | Y | null | CETUXIMAB + IRINOTECAN + MDG | 101816024 |
| 20215262 | 20130315 | 1.74 | 90.7 | null | 2019-11-25 | 2020-01-18 | EOX | Y | null | TRIAL | 100027391 |
| 20215265 | 20130316 | 1.72 | 129.2 | Curative (C) | 2016-04-15 | 2017-08-20 | Trial Unspecified | 02 | N | TRIAL | 100272429 |
| 20215266 | 20130317 | 1.85 | 77.25 | Palliative (P) | 2018-12-31 | 2019-01-17 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100084391 |
| 20215271 | 20130318 | 1.64 | 112.8 | Curative (C) | 2018-08-25 | 2018-12-17 | CAPECITABINE + RT | 02 | null | CAPECITABINE + RT | 100286930 |
| 20215272 | 20130319 | 1.78 | 60 | Neo-adjuvant (N) | 2019-06-29 | 2019-06-29 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100371361 |
| 20215274 | 20130320 | 1.58 | 69.9 | Neo-adjuvant (N) | 2019-03-18 | 2019-04-01 | Sorafenib | N | N | TRIAL | 101146999 |
| 20215275 | 20130321 | 1.52 | 106.6 | Palliative (P) | 2017-11-13 | 2018-03-12 | Trial Unspecified | Y | null | TRIAL | 100897031 |